Cellmig Biolabs
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
790 Memorial Dr, Cambridge, Massachusett...Website
www.cellmig.comRevenue
<$5 MillionIndustry
About Cellmig Biolabs
Cellmig is a global leading biopharmaceutical company focused on developing innovative medicines and medical devices aimed at combating cancer. The company specializes in creating novel molecules and biomedicines for the early diagnosis of tumor metastasis and the treatment of various cancers. With a dedicated team, Cellmig is committed to improving the quality of life for cancer patients worldwide. Their research and development efforts are centered on translating groundbreaking discoveries into effective cancer therapies.Explore more
SIC Code 28,283NAICS Code 32,325Show moreCellmig Biolabs Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Cellmig Biolabs
Compare insights from companies similar to Cellmig Biolabs, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cellmig Biolabs Tech Stack
A closer look at the technologies used by Cellmig Biolabs
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cellmig Biolabs
Sign Up For FreeTo access detailed company insights
Cellmig is a global leading biopharmaceutical company focused on developing innovative medicines and medical devices aimed at combating cancer. The company specializes in creating novel molecules and biomedicines for the early diagnosis of tumor metastasis and the treatment of various cancers. With a dedicated team, Cellmig is committed to improvin... Read More
